Background/aims:: To study the frequency of 17p(p53) loss of heterozygosity (LOH) and increased 4N and /or aneuploidy in gastric adenocarcinoma and chronic atrophic gastritis(CAG ). We reported 17p(p53)LOH, may be an important prognostic factor in early gastric carcinoma.
INTRODUCTION
A high incidence of gastric adenocarcinoma has been regularly seen in the eastern region of Turkey for years( 1 ). The development of as gastric cancer in humans has been shown to be a multi step process, ranging from chronic gastritis to atrophy, intestinal metaplasia, dysplasia and finally gastric cancer( 2 , 3 , 4 , 5 ).
We reported that development of gastric cancer, based on 17p(p53) LOH, could be important prognostic factor in early gastric carcinoma. There is a type of early gastric carcinoma with a poor prognosis, mainly due to early hematogenous recurrence ( 6 , 7 , 8 ). It has, therefore, been suggested that early carcinoma of the stomach involves various patterns of growth related to the mode recurrence and prognosis. Mutation or allelic deletion of p53 gene appears to play an important role in the development of human carcinoma( 9 , 10 , 11 ) . It has been established that accumulation of wild-type p53 protein results in two pathways; Cell cycle arrest and programmed cell death, which together are involved in tumor suppressor functions ( 12 ) . Therefore mutation of p53 leads to disruption of these pathways, a selective growth advantage for tumor cells and loss of function may result in increased proliferation activity and tumor development ( 13 , 14 ) . However, multiple somatic genetic lesions develop during the multiple step progression to cancer and it is likely that a single biomarker will assess only one or a limited number of stages of progression. Therefore, a panel of biomarkers will probably be needed for risk stratification for endoscopic surveillance and intervention strategies tailored to stage of progression ( 15 ).
p53 gene is a cell cycle control gene that prevents cells with DNA breaks from entering DNA synthesis where the breaks could be replicated cause chromosome damage and lead to progressive genetic instability and cancer ( 16 , 17 ) . The p53 gene is located at chromosome 17p (p53 locus). Most people inherit two normal alleles of p53, one from the mother and one from the father. Inactivation of the p53 gene involves a two-step mechanism consisting of a point mutation on one allele, consistent with Knudson's two-hit hypothesis. One copy is typically inactivated by mutation, whereas the second copy is lost by a mechanism called 17p loss of heterozygosity (LOH). p53+/+ cells respond to genotoxic injury by undergoing cell cycle arrest or programmed cell arrest or programmed cell death. However, p53-/-cells do not arrest in the presence of DNA damage and continue to proliferate, accumulating genetic lesions that lead to cancer ( 12 , 13 , 15 , 18 Thus, 17p(p53) LOH is a promising biomarker for assessing risk of neoplastic progression in gastric carcinoma. In this study, we demonstrated that LOH involving p53 occurs in 51.21% of gastric cancers and 30.23% CAG. We aimed to evaluate biopsies of gastric cancer and CAG related to p53-LOH and aneuploidies.
MATERIALS AND METHODS

PATIENTS
A hundred patients who had gastric complains, no history of gastric malignancy and an endoscopic biopsy evaluation were involved in the study in University hospital of Erzurum that is eastern part of Turkey between January 2004 and July 2006.
A total of 100 patients, including 68 men and 32 women underwent basic drug treatment to modulate stomach acidity. 84 of these have had endoscopies. Biopsies were pathologically assessed and 41 of then were diagnosed as gastric carcinoma and 43 of them were diagnosed as chronic atrophic gastritis (9 negative for dysplasia , 5 indefinite ,10 low-grade dysplasia and 19 high-grade dysplasia ).
ENDOSCOPY AND BIOPSY
Multiple biopsies were taken and endoscopically visible abnormalities samples were sent to pathology. Biopsies were classified according to the extent of abnormality [negative for dysplasia, indefinite, low-grade dysplasia (LGD), highgrade dysplasia (HGD) in chronic atrophic gastritis (CAG), and gastric cancer] interpretations were made without knowledge of 17p(p53)LOH or flow cytometric status.
PCR ANALYSIS
The PCR was performed by using one thermal cycle (PE 9700) with 50 ng of genomic DNA extracted from biopsy samples, 20 pmol of each primer, all four deoxynucleotide triphosphates (dNTPs), reaction buffer and 1µl (5 units) of fermentase Taq polymerase in a reaction volume of 100 µl. The PCR reaction consisted of an initial cycle of at 95°C 10 min, at 57°C 1 min and at 72°C 10 sec, followed by 34 cycle of at 95°C 1min, at 57 °C 30 sec and 72 °C 10 sec.
The primer used were
The amplicon of 66bp was produced which was cleaved in to fragments of 29 and 37 bp with the enzyme BstU1, if its recognition site (CGCG) was present. The primer pairs amplified a region containing codon 72 in exon 4 of p53 (27, 28) .
FLOW CYTOMETRY
All collected biopsy samples were frozen in DMSO and kept at -60 °C. These samples were processed by Ki-67/DNA content flow cytometry as described in Reid B. J. et al ( 29 ) . Ki-67 recognize an antigen expressed in G1, S and G2, but not G0 phases of cell cycle ( 30 ). Evaluation and classification were made according to Reid B.J. et al., study ( 29 (Figure 1 ).
Amplicons from cancer and non-cancer samples (CAG) are then digested with BstUI and run on the PAGE (Figure 2 ). 17p(p53) LOH was common in well differentiated biopsies of gastric carcinomas. 
PREVALENCE OF FLOW CYTOMETRIC ABNORMALITIES (INCREASED 4N, AND ANEUPLOIDY) AND 17(P53) LOH OF THE GASTRIC CARCINOMAS SAMPLES
Flow cytometric analysis of the gastric cancer samples showed increased 4N and/or aneuploid cell populations (18 of 41 flow cytometric content of 43.9%). Prevalence of 17p(p53) LOH, increased 4N fractions and aneuploidy were observed in different grades of malignancies at the baseline endoscopy for patients, which are represented in Figure 3 . For flow cytometric analysis, the prevalence of elevated 4N and/or aneuploidy increased from (3 of 8) 38% in patients who were poorly differentiated to (4 of 12) 33% in patients who had moderately differentiated and (11 of 21) 52% who were well differentiated (Table 1) . 17p(p53) LOH increased from (2 of 8) 25% in patients whose biopsy samples were poorly differentiated to (5 of 12) 42% in patients who had moderately differentiated and (14 of 21) 67% in patients who had well differentiated (Table 1 ). Figure 4 . For flow cytometric analysis, the prevalence of elevated 4N and/or aneuploidy increased from (8 of 19) 42% in patients who were HGD to (2 of 10) 20% in patients who had LGD and (1 of 9) 11% negative for dysplasia (Table 2 ). 17p(p53) LOH decreased from (9 of 19) 47 % in patients whose biopsy samples were HGD to (3 of 10) 30% in patients who had LGD and (1 of 5) 20 % in patients who had indefinite for dysplasia (Table 2 ).
There was correlation between prevalence of 17p(p53) LOH in histological type(p=0.04) of CAG. The prevalence 17p(p53)LOH was not related to patients' age, sex, localization and histological grade of CAG. Similarly, no relationship was detected between increased 4N or aneuploidy and patients' age, sex, localization , histological grade and histological type of CAG (Table 2 ). This pattern of results show that more frequent 17p(p53) LOH arise rapidly as a quite late event during gastric cancer.
CORRELATION BETWEEN 17P(P53) LOH AND INCREASED 4N AND/OR ANEUPLOIDY
Of 21 17p(p53)LOH positive tumors, 13 (62%) showed 4N increased or aneuploidy. The incidence of 17p(p53)LOH was higher in the 4N increased or aneuploidy positive tumors than in the other tumors (p=0.017) ( Table 3 ). Of 13 17p(p53)LOH positive benign biopsies, 8 (61%) showed 4N increased or aneuploidy. We found association between the presence of LOH and 4N increased or aneuploidy of CAG in our study(p = 0.001) (Table4). In our study, the prevalence of 17p(p53)LOH increased from 0% in patients whose biopsy specimens were negative for dysplasia to 47% in patients who had HGD (p = 0.042). Thus, inactivation of p53 may be a feature of neoplastic transformation in CAG.
The correlation was found between 17p(p53)LOH and increased 4N or aneuploidy of gastric cancer. Similarly, there was correlation between prevalence of 17p(p53) and differentiation increased 4N or aneuploidy of CAG. Our results indicate that 17p (p53) LOH, increased 4N fractions or aneuploidy are all predictors of progression to gastric adenocarcinoma in CAG, providing a panel of objective biomarkers that can be measured in a single endoscopic biopsy and used for risk assessment. 
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